|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 759.24 USD | -0.44% |
|
+13.80% | -1.64% |
| Market Cap | 75.81B 65.89B 61.52B 56.47B 106B 7,226B 108B 725B 284B 3,604B 285B 278B 11,886B | P/E 2026 * |
18x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 68.95B 59.92B 55.94B 51.36B 96.84B 6,572B 98.52B 660B 258B 3,277B 259B 253B 10,809B | EV / Sales 2026 * |
4.08x | EV / Sales 2027 * | 3.56x |
| Free-Float |
73.31% | Yield 2026 * |
0.51% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.44% | ||
| 1 week | +13.80% | ||
| Current month | -0.44% | ||
| 1 month | +16.04% | ||
| 3 months | +8.24% | ||
| 6 months | +0.01% | ||
| Current year | -1.64% |
| 1 week | 691 |  | 772.75 |
| 1 month | 637.72 | | 772.75 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/7/26 | Sell | Director | -200 | 0.0002% | ||
| 19/2/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 9/2/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | +13.80% | +35.85% | -1.58% | 76.15B | |
| -0.67% | -9.93% | +19.77% | +179.40% | 48.89B | |
| -4.18% | +42.30% | +42.30% | +42.30% | 47.83B | |
| +2.00% | +6.16% | -52.10% | -52.15% | 41.37B | |
| -0.56% | +0.84% | +52.95% | -24.62% | 29.99B | |
| -0.91% | -0.37% | +56.67% | +82.26% | 24.23B | |
| +0.58% | -0.88% | +99.75% | -49.85% | 21.89B | |
| -0.06% | -4.51% | -7.59% | +161.74% | 19.25B | |
| -7.35% | -6.03% | +64.90% | +113.10% | 17.14B | |
| -0.16% | -4.95% | +68.80% | +149.10% | 15.66B | |
| Average | -1.18% | -0.26% | +38.13% | +59.97% | 34.24B | |
| Weighted average by Cap. | -0.99% | +1.16% | +31.40% | +46.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.9B 14.69B 13.71B 12.59B 23.74B 1,611B 24.15B 162B 63.33B 803B 63.48B 62.08B 2,650B | 18.31B 15.91B 14.86B 13.64B 25.72B 1,745B 26.17B 175B 68.61B 870B 68.78B 67.26B 2,871B |
| Net income | 4.61B 4B 3.74B 3.43B 6.47B 439B 6.58B 44.07B 17.26B 219B 17.3B 16.92B 722B | 5.35B 4.65B 4.34B 3.99B 7.52B 510B 7.65B 51.21B 20.06B 254B 20.11B 19.66B 839B |
| Net Debt | -6.87B -5.97B -5.57B -5.12B -9.65B -655B -9.81B -65.71B -25.74B -326B -25.8B -25.23B -1,077B | -10.55B -9.17B -8.56B -7.86B -14.82B -1,006B -15.08B -101B -39.55B -502B -39.64B -38.76B -1,655B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | USD 759.24 | -0.44% | 842,623 |
| 31/07/26 | USD 762.63 | +3.29% | 1,158,583 |
| 30/07/26 | USD 738.34 | +6.17% | 1,460,963 |
| 29/07/26 | USD 695.42 | +0.03% | 1,022,421 |
| 28/07/26 | USD 695.18 | +4.20% | 900,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
